Literature DB >> 24331399

X-linked agammaglobulinemia presenting as polymicrobial pneumonia, including Pneumocystis jirovecii.

Artemio M Jongco1, Jonathan D Gough2, Kyle Sarnataro3, David W Rosenthal4, Joanne Moreau5, Punita Ponda5, Vincent R Bonagura4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24331399      PMCID： PMC3875599          DOI： 10.1016/j.anai.2013.10.008

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN： 1081-1206            Impact factor:   6.347


× No keyword cloud information.
  19 in total

1.  Kinase mutant Btk results in atypical X-linked agammaglobulinaemia phenotype.

Authors:  H B Gaspar; M Ferrando; I Caragol; M Hernandez; J M Bertran; X De Gracia; T Lester; C Kinnon; E Ashton; T Espanol
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

2.  Pneumocystis jiroveci pneumonia as an atypical presentation of X-linked agammaglobulinemia.

Authors:  Hirokazu Kanegane; Takashi Nakano; Yoshiki Shimono; Meina Zhao; Toshio Miyawaki
Journal:  Int J Hematol       Date:  2009-04-28       Impact factor: 2.490

3.  Age dependency and mutual relations in T and B lymphocyte abnormalities in common variable immunodeficiency patients.

Authors:  M Vlková; V Thon; M Sárfyová; L Bláha; A Svobodník; J Lokaj; J Litzman
Journal:  Clin Exp Immunol       Date:  2006-02       Impact factor: 4.330

4.  B cells are required for generation of protective effector and memory CD4 cells in response to Pneumocystis lung infection.

Authors:  Frances E Lund; Melissa Hollifield; Kevin Schuer; J Louise Lines; Troy D Randall; Beth A Garvy
Journal:  J Immunol       Date:  2006-05-15       Impact factor: 5.422

5.  Toll-like receptor signaling is impaired in dendritic cells from patients with X-linked agammaglobulinemia.

Authors:  Hiromichi Taneichi; Hirokazu Kanegane; Mostafa Mohamed Sira; Takeshi Futatani; Kazunaga Agematsu; Masahiro Sako; Hideo Kaneko; Naomi Kondo; Tsuneyasu Kaisho; Toshio Miyawaki
Journal:  Clin Immunol       Date:  2008-02       Impact factor: 3.969

6.  CD4 lymphocyte subset abnormalities associated with impaired delayed cutaneous hypersensitivity reactions in patients with X-linked agammaglobulinaemia.

Authors:  A D Crockard; N A Boyd; T A McNeill; D R McCluskey
Journal:  Clin Exp Immunol       Date:  1992-04       Impact factor: 4.330

7.  A case of Pneumocystis jiroveci pneumonia in X-linked agammaglobulinaemia treated with immunosuppressive therapy: a lesson for immunologists.

Authors:  Maria Caterina Sirianni; Chiara Atzori; Wladimiro De Santis; Cinzia Milito; Antonella Esposito; Marco Marziali; Maria Livia Bernardi; Antonietta Cargnel; Fernando Aiuti
Journal:  Int Arch Allergy Immunol       Date:  2006-03-20       Impact factor: 2.749

8.  Impaired maintenance of naturally acquired T-cell memory to the meningococcus in patients with B-cell immunodeficiency.

Authors:  Begonia Morales-Aza; Sarah J Glennie; Tomaz Pereira Garcez; Victoria Davenport; Sarah L Johnston; Neil A Williams; Robert S Heyderman
Journal:  Blood       Date:  2009-02-06       Impact factor: 22.113

9.  Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study.

Authors:  William T Shearer; Howard M Rosenblatt; Rebecca S Gelman; Rebecca Oyomopito; Susan Plaeger; E Richard Stiehm; Diane W Wara; Steven D Douglas; Katherine Luzuriaga; Elizabeth J McFarland; Ram Yogev; Mobeen H Rathore; Wende Levy; Bobbie L Graham; Stephen A Spector
Journal:  J Allergy Clin Immunol       Date:  2003-11       Impact factor: 10.793

10.  Predicting the functional effect of amino acid substitutions and indels.

Authors:  Yongwook Choi; Gregory E Sims; Sean Murphy; Jason R Miller; Agnes P Chan
Journal:  PLoS One       Date:  2012-10-08       Impact factor: 3.240
View more
  2 in total

1.  Chronic Aichi Virus Infection in a Patient with X-Linked Agammaglobulinemia.

Authors:  Giorgia Bucciol; Leen Moens; Kathryn Payne; Elke Wollants; Djalila Mekahli; Elena Levtchenko; François Vermeulen; Thomas Tousseyn; Paul Gray; Cindy S Ma; Stuart G Tangye; Marc Van Ranst; Julianne R Brown; Judy Breuer; Isabelle Meyts
Journal:  J Clin Immunol       Date:  2018-10-11       Impact factor: 8.317

Review 2.  Ibrutinib in primary central nervous system diffuse large B-cell lymphoma.

Authors:  Justin T Low; Katherine B Peters
Journal:  CNS Oncol       Date:  2020-03-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.